Top Module Empty

首页

项目

KOL Conference

There is no translation available, please select a different language.

December 9th 2010, Royalton – Shanghai, CHINA

As pharmaceutical and life-sciences companies search for the most effective, efficient ways to manage collaboration with the physicians who conduct research, write articles, or speak on their behalf, relationship management of the interaction with these elite physicians, or key opinion leaders (KOLs), has ultimately emerged as an individual business discipline. KOL management is an essential component for marketers and medical staff throughout the life-cycle process of a specific drug or product.

Key Highlight

Overview of Chinese market characteristics

Understand the complexity of the relationship between the actors

Meet the most experienced executives who have daily contact with KOLs

Understand the opinion cascade down to the prescribing medical community

KOL identification and segmentation

Meet the Chinese experts for major diseases

Importance of KOLs all along the product lifecycle

Build and maintain a strong relationship with KOLs in China

For more information, please visit our website .

China Market Access

There is no translation available, please select a different language.

China Market Access Conference

A satellite event of the Innovation Days – Paris – France

These past years the global pharmaceutical industry has been experiencing a shift in its development: a geographic swing away from the major mature markets - US, Japan and top 5 European countries - to a set of new dynamics in pharmerging countries.

Annual pharmaceutical sales in emerging countries are expecting to reach $400 bln by 2020, equivalent to current sales in the US and the top 5 European markets combined.
Moreover, the China pharmaceutical market is expected to hit $200 billion by 2020, making it the 2nd largest in the world, before Japan.
Your company needs to take this country into consideration for development strategies.

Key Highlights

•   Understand opportunities and challenges in emerging markets
•   Meet experts in China drug registration
•   Meet opinion leaders from China's official institutions
•   Network with managers who have the same approach

For more information, don’t hesitate to visit the event’s website.

中国医药客户关系研讨会回顾